ERBB2 and neoplasm: The prognostic significance of infiltrating immune cells as a key component of the tumor microenvironment has been recognized for breast cancer, and a positive correlation between lymphocyte infiltration or expression of lymphocyte-associated genes and HER2 amplification/overexpression in breast cancer has been reported [30, 31].